FindTrial
Sign In

A predictive model for atrial fibrillation after thoracoscopic anatomic lung cancer surgery

A Novel Nomogram for Predicting New Clinically Important Atrial Fibrillation after Thoracoscopic Lung Cancer Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060420
Enrollment
Unknown
Registered
2022-06-01
Start date
2022-05-20
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Postoperative atrial fibrillation group:None
No postoperative atrial fibrillation group:None

Sponsors

Department of Anesthesiology, Shanghai Chest Hospital, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 87 Years

Inclusion criteria

Inclusion criteria: Patients who received thoracoscopic anatomic lung cancer surgery in our hospital from January 2016 to December 2018.

Exclusion criteria

Exclusion criteria: 1. Patients with atrial fibrillation or non-sinus rhythm before surgery; 2. Patients with emergency pulmonary resection; 3. Thoracoscopic sleeve lobectomy and pneumonectomy; 4. Bilateral lung tissue resection; 5. Benign lung disease; 6. Data is missing.

Design outcomes

Primary

MeasureTime frame
Postoperative pulmonary complications;—

Secondary

MeasureTime frame
Length of hospital stay;30 days of apoplexy/peduncle;—

Countries

China

Contacts

Public ContactWu Jingxiang
wjx1132xk@163.com+86 18930857186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026